Bone mineral density in patients on maintenance dialysis

International Urology and Nephrology

Volumn 42, Issue 3, 2010, Pages 723-739

  Ambrus, Csaba ^a,b   Marton, Adrienn ^a   Nemeth, Zsofia Klara ^a   Mucsi, Istvan ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Bone fracture; Bone mineral density; Chronic kidney disease; Dialysis; Hyperparathyroidism

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CINACALCET; DENOSUMAB; FIBROBLAST GROWTH FACTOR 23; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PAMIDRONIC ACID; PARATHYROID HORMONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

BONE DENSITY; BONE METABOLISM; BONE MINERALIZATION; BONE TURNOVER; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; HEMODIALYSIS; HORMONE RELEASE; HUMAN; HYPERPARATHYROIDISM; KIDNEY DISEASE; MORPHOMETRICS; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOPOROSIS; PERITONEAL DIALYSIS; PREVALENCE; RENAL OSTEODYSTROPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UPREGULATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; ESTROGENS; FIBROBLAST GROWTH FACTORS; FRACTURES, SPONTANEOUS; HUMANS; KIDNEY FAILURE, CHRONIC; OSTEOPROTEGERIN; PARATHYROID HORMONE; PERITONEAL DIALYSIS; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; RISK FACTORS; VITAMIN D DEFICIENCY;

EID: 78549285611     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9666-2     Document Type: Review

References (119)

1. AM Alem DJ Sherrard DL Gillen, et al. 2000 Increased risk of hip fracture among patients with end-stage renal disease Kidney Int 58 396 399 10886587
2. M Jadoul JM Albert T Akiba, et al. 2006 Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study Kidney Int 70 1358 1366 16929251
3. M Coco H Rush 2000 Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone Am J Kidney Dis 36 1115 1121 11096034
4. A Mittalhenkle DL Gillen CO Stehman-Breen 2004 Increased risk of mortality associated with hip fracture in the dialysis population Am J Kidney Dis 44 672 679 15384018
5. M Ketteler ML Gross E Ritz 2005 Calcification and cardiovascular problems in renal failure Kidney Int 94 Suppl S120 S127
6. K Matsubara ME Suliman AR Qureshi, et al. 2008 Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality Blood Purif 26 284 290 18421213
7. S Moe T Drueke J Cunningham, et al. 2006 Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO) Kidney Int 69 1945 1953 16641930
8. C Roux M Dougados 2000 Quantitative ultrasound in postmenopausal osteoporosis Curr Opin Rheumatol 12 336 345 10910188
9. D Hans T Fuerst M Uffmann 1996 Bone density and quality measurement using ultrasound Curr Opin Rheumatol 8 370 375 8864591
10. CC Gluer 1997 Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status The International Quantitative Ultrasound Consensus Group. J Bone Miner Res 12 1280 1288
11. DC Bauer CC Gluer JA Cauley, et al. 1997 Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 157 629 634
12. A Peretz A Penaloza M Mesquita, et al. 2000 Quantitative ultrasound and dual X-ray absorptiometry measurements of the calcaneus in patients on maintenance hemodialysis Bone 27 287 292 10913924
13. W Pluskiewicz P Adamczyk B Drozdzowska, et al. 2003 Skeletal status in children and adolescents with chronic renal failure before onset of dialysis or on dialysis Osteoporos Int 14 283 288 12730774
14. J Przedlacki W Pluskiewicz M Wieliczko, et al. 1999 Quantitative ultrasound of phalanges and dual-energy X-ray absorptiometry of forearm and hand in patients with end-stage renal failure treated with dialysis Osteoporos Int 10 1 6 10501772
15. B Tribl H Vogelsang E Pohanka, et al. 1998 Broadband ultrasound attenuation of the calcaneus. A tool for assessing bone status in patients with chronic renal failure Acta Radiol 39 637 641 9817034
16. Y Duan V De Luca E Seeman 1999 Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone J Clin Endocrinol Metab 84 718 722 10022443
17. SA Jamal C Chase YI Goh, et al. 2002 Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures Am J Kidney Dis 39 843 849 11920352
18. Q Chen H Kaji MF Iu, et al. 2003 Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects J Clin Endocrinol Metab 88 4655 4658 14557436
19. CR Russo G Taccetti P Caneva, et al. 1998 Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis Osteoporos Int 8 443 448 9850352
20. SA Jamal J Gilbert C Gordon, et al. 2006 Cortical pQCT measures are associated with fractures in dialysis patients J Bone Miner Res 21 543 548 16598374
21. SM Ott 2008 Histomorphometric measurements of bone turnover, mineralization, and volume Clin J Am Soc Nephrol 3 Suppl 3 S151 156 18988700
22. J Cunningham SM Sprague J Cannata-Andia, et al. 2004 Osteoporosis in chronic kidney disease Am J Kidney Dis 43 566 571 14981616
23. S Dolgos A Hartmann S Bonsnes, et al. 2008 Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation Clin Transplant 22 462 468 18318737
24. MW Taal T Masud D Green, et al. 1999 Risk factors for reduced bone density in haemodialysis patients Nephrol Dial Transplant 14 1922 1928 10462272
25. T Yamaguchi E Kanno J Tsubota, et al. 1996 Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures Bone 19 549 555 8922656
26. FF Ersoy SP Passadakis P Tam, et al. 2006 Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients J Bone Miner Metab 24 79 86 16369903
27. NS Krieger KK Frick DA Bushinsky 2004 Mechanism of acid-induced bone resorption Curr Opin Nephrol Hypertens 13 423 436 15199293
28. R Mehrotra JD Kopple M Wolfson 2003 Metabolic acidosis in maintenance dialysis patients: clinical considerations Kidney Int 64 Suppl S13 25
29. T Eleftheriadis C Kartsios G Antoniadi, et al. 2008 The impact of chronic inflammation on bone turnover in hemodialysis patients Ren Fail 30 431 437 18569918 (Pubitemid 351868698)
30. GJ Elder K Mackun 2006 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease J Bone Miner Res 21 1778 1784 17002574
31. AL Negri R Barone C Lombas, et al. 2006 Evaluation of cortical bone by peripheral quantitative computed tomography in continuous ambulatory peritoneal dialysis patients Hemodial Int 10 351 355 17014510
32. P Urena O Bernard-Poenaru A Ostertag, et al. 2003 Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients Nephrol Dial Transplant 18 2325 2331 14551361
33. P Joffe J Podenphant JG Heaf 1989 Bone histology in CAPD patients: a comparison with hemodialysis and conservatively treated chronic uremics Adv Perit Dial 5 171 176 2577405
34. CO Stehman-Breen D Sherrard A Walker, et al. 1999 Racial differences in bone mineral density and bone loss among end-stage renal disease patients Am J Kidney Dis 33 941 946 10213653
35. H Taskapan M Wei DG Oreopoulos 2006 25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance Int Urol Nephrol 38 323 329 16868705
36. MF Holick 2007 Vitamin D deficiency N Engl J Med 357 266 281 17634462
37. E Del Valle AL Negri C Aguirre, et al. 2007 Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis Hemodial Int 11 315 321 17576296
38. R Mehrotra D Kermah M Budoff, et al. 2008 Hypovitaminosis D in chronic kidney disease Clin J Am Soc Nephrol 3 1144 1151 18417740
39. H Taskapan FF Ersoy PS Passadakis, et al. 2006 Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis Clin Nephrol 66 247 255 17063991
40. G Sahin I Kirli B Sirmagul, et al. 2009 Loss via peritoneal fluid as a factor for low 25(OH)D3 level in peritoneal dialysis patients Int Urol Nephrol 41 989 996 19404765
41. S Shany J Rapoport M Goligorsky, et al. 1984 Losses of 1, 25- and 24, 25-dihydroxycholecalciferol in the peritoneal fluid of patients treated with continuous ambulatory peritoneal dialysis Nephron 36 111 113 6607420
42. Y Aloni S Shany C Chaimovitz 1983 Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis Miner Electrolyte Metab 9 82 86 6601753
43. HA Bischoff-Ferrari T Dietrich EJ Orav, et al. 2004 Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults Am J Med 116 634 639 15093761
44. K Tomida T Hamano S Mikami, et al. 2009 Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients Bone 44 678 683 19111635
45. A Fournier P Bordier J Gueris, et al. 1979 Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization Kidney Int 15 196 204 513484
46. A Ghazali P Fardellone A Pruna, et al. 1999 Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int 55 2169 2177 10354266
47. I Mucsi C Almasi G Deak, et al. 2005 Serum 25(OH)-vitamin D levels and bone metabolism in patients on maintenance hemodialysis Clin Nephrol 64 288 294 16240900
48. G Coen D Mantella M Manni, et al. 2005 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy Kidney Int 68 1840 1848 16164662
49. JR Weisinger L Gonzalez H Alvarez, et al. 2000 Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women Kidney Int 58 331 335 10886579
50. JL Holley RJ Schmidt FH Bender, et al. 1997 Gynecologic and reproductive issues in women on dialysis Am J Kidney Dis 29 685 690 9159301
51. J Matuszkiewicz-Rowinska K Skorzewska S Radowicki, et al. 1999 The benefits of hormone replacement therapy in pre-menopausal women with oestrogen deficiency on haemodialysis Nephrol Dial Transplant 14 1238 1243 10344368 (Pubitemid 29209314)
52. DJ Sherrard G Hercz Y Pei, et al. 1993 The spectrum of bone disease in end-stage renal failure-an evolving disorder Kidney Int 43 436 442 8441240
53. AJ Hutchison RW Whitehouse HF Boulton, et al. 1993 Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease Kidney Int 44 1071 1077 8264137
54. HC Schober ZH Han AJ Foldes, et al. 1998 Mineralized bone loss at different sites in dialysis patients: implications for prevention J Am Soc Nephrol 9 1225 1233 9644632
55. M Haas Z Leko-Mohr P Roschger, et al. 2002 Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients Am J Kidney Dis 39 580 586 11877577
56. FC Barreto DV Barreto RM Moyses, et al. 2006 Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem Kidney Int 69 1852 1857 16612334
57. M Wang G Hercz DJ Sherrard, et al. 1995 Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity Am J Kidney Dis 26 836 844 7485142
58. A Gerakis AJ Hutchison T Apostolou, et al. 1996 Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis Nephrol Dial Transplant 11 2430 2438 9017618
59. LD Quarles B Lobaugh G Murphy 1992 Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia J Clin Endocrinol Metab 75 145 150 1619003
60. C Sanchez F Lopez-Barea J Sanchez-Cabezudo, et al. 2004 Low vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study Nephrol Dial Transplant 19 1587 1593 15069173
61. MC Monier-Faugere HH Malluche 1996 Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients Nephrol Dial Transplant 11 Suppl 3 111 120 8840325
62. PG Lacativa LM de Mendonca PJ de Mattos Patricio Filho, et al. 2005 Risk factors for decreased total body and regional bone mineral density in hemodialysis patients with severe secondary hyperparathyroidism J Clin Densitom 8 352 361 16055968
63. G Hercz Y Pei C Greenwood, et al. 1993 Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function Kidney Int 44 860 866 8258962
64. Y Pei G Hercz C Greenwood, et al. 1993 Renal osteodystrophy in diabetic patients Kidney Int 44 159 164 8355457
65. M Rix H Andreassen P Eskildsen, et al. 1999 Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure Kidney Int 56 1084 1093 10469378
66. M Inaba S Okuno K Nagasue, et al. 2001 Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients Am J Kidney Dis 38 S139 S142 11576940
67. M Inaba S Okuno Y Kumeda, et al. 2005 Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus Calcif Tissue Int 76 256 260 15692725
68. I Mucsi G Hercz 1999 Relative hypoparathyroidism and adynamic bone disease Am J Med Sci 317 405 409 10372841
69. T Wada T Nakashima N Hiroshi, et al. 2006 RANKL-RANK signaling in osteoclastogenesis and bone disease Trends Mol Med 12 17 25 16356770
70. Y Li G Toraldo A Li, et al. 2007 B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo Blood 109 3839 3848 17202317
71. MR McClung 2006 Inhibition of RANKL as a treatment for osteoporosis: preclinical and early clinical studies Curr Osteoporos Rep 4 28 33 16527005
72. M Mesquita E Wittersheim A Demulder, et al. 2005 Bone cytokines and renal osteodystrophy in peritoneal dialysis patients Adv Perit Dial 21 181 184 16686314
73. M Shaarawy SA Fathy NL Mehany, et al. 2007 Circulating levels of osteoprotegerin and receptor activator of NF-kappaB ligand in patients with chronic renal failure Clin Chem Lab Med 45 1498 1503 17970704
74. A Fahrleitner-Pammer H Dobnig HP Dimai, et al. 2009 The effect of RANKL and OPG on bone mineral density in pre-dialysis chronic renal failure Clin Nephrol 71 652 659 19473634
75. K Doumouchtsis D Perrea S Doumouchtsis, et al. 2009 Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease Ther Apher Dial 13 49 55 19379170
76. G Speer BC Fekete T El Hadj Othmane, et al. 2008 Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients Nephrol Dial Transplant 23 3256 3262 18450827
77. CP Kovesdy K Kalantar-Zadeh 2008 Bone and mineral disorders in pre-dialysis CKD Int Urol Nephrol 40 427 440 18368510
78. H Wang Y Yoshiko R Yamamoto, et al. 2008 Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro J Bone Miner Res 23 939 948 18282132
79. D Sitara MS Razzaque R St-Arnaud, et al. 2006 Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals Am J Pathol 169 2161 2170 17148678
80. H Kurosu Y Ogawa M Miyoshi, et al. 2006 Regulation of fibroblast growth factor-23 signaling by klotho J Biol Chem 281 6120 6123 16436388
81. I Urakawa Y Yamazaki T Shimada, et al. 2006 Klotho converts canonical FGF receptor into a specific receptor for FGF23 Nature 444 770 774 17086194
82. M Kuro-o Y Matsumura H Aizawa, et al. 1997 Mutation of the mouse klotho gene leads to a syndrome resembling ageing Nature 390 45 51 9363890
83. Y Imanishi M Inaba K Nakatsuka, et al. 2004 FGF-23 in patients with end-stage renal disease on hemodialysis Kidney Int 65 1943 1946 15086938
84. PU Torres D Prie V Molina-Bletry, et al. 2007 Klotho: an antiaging protein involved in mineral and vitamin D metabolism Kidney Int 71 730 737 17332731
85. F Kojima K Uchida T Ogawa, et al. 2008 Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis Int Urol Nephrol 40 1067 1074 18791804
86. DW Johnson KA Herzig DM Purdie, et al. 2000 Is obesity a favorable prognostic factor in peritoneal dialysis patients? Perit Dial Int 20 715 721 11216565
87. JJ Mottet FF Horber JP Casez, et al. 1996 Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis J Bone Miner Res 11 96 104 8770702
88. G Hampson S Vaja C Evans, et al. 2002 Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis Nephron 91 94 102 12021525
89. P Pasadakis E Thodis J Manavis, et al. 1995 The identification of bone mineral density in CAPD in comparison with HD patients Adv Perit Dial 11 247 253 8534716
90. MM Couttenye PC D'Haese JT Deng, et al. 1997 High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population Nephrol Dial Transplant 12 2144 2150 9351080
91. A Haris DJ Sherrard G Hercz 2006 Reversal of adynamic bone disease by lowering of dialysate calcium Kidney Int 70 931 937 16837920
92. P Kurz T Tsobanelis P Roth, et al. 1995 Differences in calcium kinetic pattern between CAPD and HD patients Clin Nephrol 44 255 261 8575126
93. AL Negri R Barone MA Quiroga, et al. 2004 Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis Perit Dial Int 24 163 168 15119637
94. CO Stehman-Breen DJ Sherrard AM Alem, et al. 2000 Risk factors for hip fracture among patients with end-stage renal disease Kidney Int 58 2200 2205 11044242
95. MD Danese J Kim QV Doan, et al. 2006 PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis Am J Kidney Dis 47 149 156 16377396
96. BL White WD Fisher CA Laurin 1987 Rate of mortality for elderly patients after fracture of the hip in the 1980's J Bone Joint Surg Am 69 1335 1340 3440792
97. K Atsumi K Kushida K Yamazaki, et al. 1999 Risk factors for vertebral fractures in renal osteodystrophy Am J Kidney Dis 33 287 293 10023640
98. SA Jamal JA Hayden J Beyene 2007 Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis Am J Kidney Dis 49 674 681 17472850
99. GB Spasovski 2007 Bone health and vascular calcification relationships in chronic kidney disease Int Urol Nephrol 39 1209 1216 17899431
100. GM London C Marty SJ Marchais, et al. 2004 Arterial calcifications and bone histomorphometry in end-stage renal disease J Am Soc Nephrol 15 1943 1951 15213285
101. LB Tanko C Christiansen DA Cox, et al. 2005 Relationship between osteoporosis and cardiovascular disease in postmenopausal women J Bone Miner Res 20 1912 1920 16234963
102. T Adragao J Herberth MC Monier-Faugere, et al. 2009 Low bone volume-a risk factor for coronary calcifications in hemodialysis patients Clin J Am Soc Nephrol 4 450 455 19158372
103. ND Toussaint KK Lau BJ Strauss, et al. 2008 Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease Nephrol Dial Transplant 23 586 593 17933842
104. WS Browner DG Seeley TM Vogt, et al. 1991 Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group Lancet 338 355 358 1677708
105. P von der Recke MA Hansen C Hassager 1999 The association between low bone mass at the menopause and cardiovascular mortality Am J Med 106 273 278
106. MW Taal S Roe T Masud, et al. 2003 Total hip bone mass predicts survival in chronic hemodialysis patients Kidney Int 63 1116 1120 12631095
107. G Jean JC Terrat T Vanel, et al. 2008 Daily oral 25- hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers Nephrol Dial Transplant 23 3670 3676 18579534
108. E Baskin S Ozen M Karcaaltincaba, et al. 2004 Beneficial role of intravenous calcitriol on bone mineral density in children with severe secondary hyperparathyroidism Int Urol Nephrol 36 113 118 15338687
109. SX Wang H Li 2008 Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients Chin Med J (Engl) 121 1280 1284
110. PJ Bekker DL Holloway AS Rasmussen, et al. 2005 A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. 2004 J Bone Miner Res 20 2275 2282 16432953
111. JB Wetmore LZ Benet D Kleinstuck, et al. 2005 Effects of short-term alendronate on bone mineral density in haemodialysis patients Nephrology (Carlton) 10 393 399
112. ND Toussaint GJ Elder PG Kerr 2009 Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue Clin J Am Soc Nephrol 4 221 233 18987295
113. WD Fraser FC Logue JP Christie, et al. 1998 Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis Osteoporos Int 8 121 126 9666934
114. JE Onyia RR Miles X Yang, et al. 2000 In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene J Bone Miner Res 15 863 871 10804015
115. JS Finkelstein A Klibanski AL Arnold, et al. 1998 Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial JAMA 280 1067 1073 9757854
116. SJ Glover R Eastell Ev McCloskey, et al. 2009 Rapid and robust response of biochemical markers of bone formation to teriparatide therapy Bone 45 1053 1058 19679211
117. T Matsumoto H Hagino M Shiraki, et al. 2009 Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study Osteoporos Int 20 1429 1437 19101754
118. YH Lien AL Silva D Whittman 2005 Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism Nephrol Dial Transplant 20 1232 1237 15840675
119. D Zayour M Daouk W Medawar, et al. 2004 Predictors of bone mineral density in patients on hemodialysis Transplant Proc 36 1297 1301 15251316